Oxcarbazepine as monotherapy of acute mania in insufficiently controlled type-1 diabetes mellitus: a case-report
2007

Oxcarbazepine for Acute Mania in Type-1 Diabetes

Sample size: 1 publication Evidence: low

Author Information

Author(s): Oulis Panagiotis, Karapoulios Evangelos, Kouzoupis Anastasios V, Masdrakis Vasilios G, Kontoangelos Konstantinos A, Makrilakis Konstantinos, Karakatsanis Nikolaos A, Papageorgiou Charalambos, Katsilambros Nikolaos, Soldatos Constantin R

Primary Institution: University of Athens, Medical School, Department of Psychiatry, Eginition Hospital, Athens, Greece

Hypothesis

Can oxcarbazepine be safely and effectively used as monotherapy for acute mania in patients with type-1 diabetes?

Conclusion

Oxcarbazepine may be a safe and effective treatment for acute mania in patients with type-1 diabetes who cannot use standard treatments.

Supporting Evidence

  • The patient's mental state improved steadily after starting oxcarbazepine.
  • She showed an improvement rate of over 70% on the Young Mania Rating Scale.
  • The patient remained normothymic 6 months after discharge.

Takeaway

A woman with type-1 diabetes and mania got better after taking oxcarbazepine, which is a medicine that helps with mood.

Methodology

Case report of a 55-year-old female treated with oxcarbazepine for acute mania.

Potential Biases

Potential bias due to the lack of randomized clinical trials.

Limitations

The study is based on a single case report, limiting generalizability.

Participant Demographics

55-year-old married female with a history of type-1 diabetes since age 11.

Digital Object Identifier (DOI)

10.1186/1744-859X-6-25

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication